TSX open
Loading markets…

Advertisement

Stocks

What's Going On With Devonian Health Group Inc Stock Monday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:GSD.V

Follow GSD

Photos provided by Pexels

Devonian Health Group Inc's stock has seen significant fluctuations recently, particularly over the past week.

Devonian Health Group Inc (GSD.V) closed at C$9.00, unchanged on the day but down 18.45% over the past week. This performance comes amidst various corporate developments that may be influencing investor sentiment.

Advertisement

Devonian Health Group Inc

GSD.V

Full stock page →

GSD.V

Devonian Health Group Inc

Source:WealthAwesomeWealthAwesome
↓ $2.25 (-21.43%)
120 day period
$5.10$10.05$15.00Sep 4Apr 15Oct 9

Market cap

$22.94M

52W high

$15.00

52W low

$0.19

1W change

+3.13%

Beta

1.14

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GSD's historical volatility

HistoricalForecast68%95%
C$1.05C$9.93C$18.82C$27.71C$36.60C$45.49TodayJan 19Jul 6Oct 9Nov 21Jan 4Feb 16

30-Day Vol

155.3%

Annualized

90-Day Vol

199.4%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$6.90

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$7.77C$4.55 – C$13.28
60 trading daysC$7.32C$3.43 – C$15.63
90 trading daysC$6.90C$2.73 – C$17.46

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should pay attention to Devonian's recent financial results and strategic plans, including its anticipated NYSE American listing, as these factors could impact future stock performance. Understanding the company's technical indicators and market position is crucial for making informed decisions.

C$9.00 closing price, reflecting a 0.00% change today.

Devonian's stock has seen a substantial decline of 29.82% year-to-date, indicating challenges in maintaining investor confidence.

Bull case

The planned NYSE American listing could boost visibility and attract institutional investors, which may drive future growth and help recover the stock price.

Bear case

The significant loss reported in the latest financial results, along with the recent drop in stock price, raises concerns about the company's financial health and operational viability.

Recent Price Action

Advertisement

Devonian Health Group Inc (GSD.V) has closed at C$9.00, showing no change today. Over the past week, the stock has experienced a notable decline of 18.45%. In the broader view, the stock is down 29.82% year-to-date, reflecting ongoing challenges within the company.

Catalysts and Company News

Recent headlines highlight Devonian's plans to list on the NYSE American, which could provide a new avenue for capital and visibility. The company is also preparing for an underwritten public offering of its common shares and warrants, with trading expected to start as early as September 16, 2026. Additionally, Devonian received Health Canada authorization for a pediatric clinical trial of Thykamine™, a promising development for its product pipeline.

Technical Picture

From a technical standpoint, Devonian Health Group's stock is currently trading above its 50-day moving average of C$8.76, indicating short-term strength, but below its 200-day moving average of C$10.80, suggesting long-term weakness. The stock's 52-week range spans from C$0.19 to C$15.00, placing the current price at 59% of its range. The beta of 1.24 indicates that the stock is more volatile than the broader market. Recent trading volumes have been low, with only 123 shares changing hands against a 20-day average of 2,767 shares, reflecting reduced investor interest.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 14, 2026
Last Updated: September 24, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement